Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.

de Hora, Mark R; Heather, Natasha L; Patel, Tejal; Bresnahan, Lauren G; Webster, Dianne; Hofman, Paul L

de Hora, Mark R; Heather, Natasha L; Patel, Tejal; Bresnahan, Lauren G; Webster, Dianne; Hofman, Paul L.

Afiliação

de Hora MR; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland, New Zealand.
Heather NL; Liggins Institute, University of Auckland, Auckland, New Zealand.
Patel T; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland, New Zealand.
Bresnahan LG; Liggins Institute, University of Auckland, Auckland, New Zealand.
Webster D; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland, New Zealand.
Hofman PL; Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital, Auckland, New Zealand.

Clin Endocrinol (Oxf) ; 94(6): 904-912, 2021 06.

Article em En | MEDLINE | ID: mdl-33471388

Assuntos

Hiperplasia Suprarrenal Congênita; Hiperplasia Suprarrenal Congênita/diagnóstico; Cromatografia Líquida; Humanos; Recém-Nascido; Triagem Neonatal; Nova Zelândia; Estudos Prospectivos; Esteroides; Espectrometria de Massas em Tandem

Palavras-chave

21-hydroxylase; congenital adrenal hyperplasia; newborn screening; tandem mass spectrometry

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Suprarrenal Congênita Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Newborn País/Região como assunto: Oceania Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google